Johnson & Johnson's one-dose vaccine will not be part of Australia's vaccine rollout, at least for now, after the federal government confirmed it would not purchased any doses from the company.
The federal government had been in talks with the global pharmaceutical giant about potentially acquiring its vaccine, and the company had previously submitted an application to the Therapeutic Goods Administration for provisional registration. .
"The [Johnson & Johnson] vaccine is an adenovirus vaccine, the same type of vaccine as the AstraZeneca vaccine," they said in a statement.
The news comes despite the fact the federal government has been considering how to increase Australia's vaccine orders in response to changing advice around the AstraZeneca vaccine.
Australia has deals in place with Pfizer, AstraZeneca and Novavax, but the Novavax vaccine is yet to be approved.